Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.

Cederholm S, Hill G, Asiimwe A, Bate A, Bhayat F, Persson Brobert G, Bergvall T, Ansell D, Star K, Norén GN.

Drug Saf. 2015 Jan;38(1):87-100. doi: 10.1007/s40264-014-0251-y.

2.

Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study.

Mutwa PR, Boer KR, Asiimwe-Kateera B, Tuyishimire D, Muganga N, Lange JM, van de Wijgert J, Asiimwe A, Reiss P, Geelen SP.

PLoS One. 2014 Nov 3;9(11):e111948. doi: 10.1371/journal.pone.0111948. eCollection 2014.

3.

Low risk of attrition among adults on antiretroviral therapy in the Rwandan national program: a retrospective cohort analysis of 6, 12, and 18 month outcomes.

Nuwagaba-Biribonwoha H, Jakubowski A, Mugisha V, Basinga P, Asiimwe A, Nash D, Elul B.

BMC Public Health. 2014 Aug 29;14:889. doi: 10.1186/1471-2458-14-889.

4.

Provider-initiated HIV testing and counselling in Rwanda: acceptability among clinic attendees and workers, reasons for testing and predictors of testing.

Kayigamba FR, Bakker MI, Lammers J, Mugisha V, Bagiruwigize E, Asiimwe A, van der Loeff MF.

PLoS One. 2014 Apr 17;9(4):e95459. doi: 10.1371/journal.pone.0095459. eCollection 2014.

5.

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.

Musiime V, Cook A, Kayiwa J, Zangata D, Nansubuga C, Arach B, Kenny J, Wavamunno P, Komunyena J, Kabamba D, Asiimwe AR, Mirembe G, Abongomera G, Mulenga V, Kekitiinwa A, Kityo C, Walker SA, Klein N, Gibb DM; CHAPAS-3 trial team.

Antivir Ther. 2014;19(3):269-76. doi: 10.3851/IMP2695. Epub 2013 Oct 25.

PMID:
24717427
6.

The human resources for health program in Rwanda--new partnership.

Binagwaho A, Kyamanywa P, Farmer PE, Nuthulaganti T, Umubyeyi B, Nyemazi JP, Mugeni SD, Asiimwe A, Ndagijimana U, Lamphere McPherson H, Ngirabega Jde D, Sliney A, Uwayezu A, Rusanganwa V, Wagner CM, Nutt CT, Eldon-Edington M, Cancedda C, Magaziner IC, Goosby E.

N Engl J Med. 2013 Nov 21;369(21):2054-9. doi: 10.1056/NEJMsr1302176. No abstract available.

7.

Shared learning in an interconnected world: innovations to advance global health equity.

Binagwaho A, Nutt CT, Mutabazi V, Karema C, Nsanzimana S, Gasana M, Drobac PC, Rich ML, Uwaliraye P, Nyemazi JP, Murphy MR, Wagner CM, Makaka A, Ruton H, Mody GN, Zurovcik DR, Niconchuk JA, Mugeni C, Ngabo F, Ngirabega Jde D, Asiimwe A, Farmer PE.

Global Health. 2013 Aug 30;9:37. doi: 10.1186/1744-8603-9-37.

8.

Diagnoses of gastrointestinal cancers after gastrointestinal bleeding in patients receiving clopidogrel or warfarin.

Asiimwe A, Li JJ, Weerakkody G, Vangerow H, Delisle F, Benoit K, Heath L, Wernicke J, Motsko S.

Curr Drug Saf. 2013 Sep;8(4):261-9.

PMID:
24102361
9.

Developing cancer control plans in Africa: examples from five countries.

Stefan DC, Elzawawy AM, Khaled HM, Ntaganda F, Asiimwe A, Addai BW, Wiafe S, Adewole IF.

Lancet Oncol. 2013 Apr;14(4):e189-95. doi: 10.1016/S1470-2045(13)70100-1.

PMID:
23561751
10.

Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda.

Tukei VJ, Murungi M, Asiimwe AR, Migisha D, Maganda A, Bakeera-Kitaka S, Kalyesubula I, Musoke P, Kekitiinwa A.

BMC Pediatr. 2013 Mar 27;13:42. doi: 10.1186/1471-2431-13-42.

11.

High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda.

Elul B, Basinga P, Nuwagaba-Biribonwoha H, Saito S, Horowitz D, Nash D, Mugabo J, Mugisha V, Rugigana E, Nkunda R, Asiimwe A.

PLoS One. 2013;8(1):e53586. doi: 10.1371/journal.pone.0053586. Epub 2013 Jan 9.

12.

Does introduction of thresholds in decision aids benefit the patient?: Comparison between findings-based and threshold-based diagnostic decision aids.

Bisig B, Moreira J, Combes M, Asiimwe A, Bisoffi Z, Haegeman F, Bottieau E, Van den Ende J.

Med Decis Making. 2012 Nov-Dec;32(6):E16-34. doi: 10.1177/0272989X12461854.

PMID:
23204241
13.

Scale-up of HIV treatment through PEPFAR: a historic public health achievement.

El-Sadr WM, Holmes CB, Mugyenyi P, Thirumurthy H, Ellerbrock T, Ferris R, Sanne I, Asiimwe A, Hirnschall G, Nkambule RN, Stabinski L, Affrunti M, Teasdale C, Zulu I, Whiteside A.

J Acquir Immune Defic Syndr. 2012 Aug 15;60 Suppl 3:S96-104. doi: 10.1097/QAI.0b013e31825eb27b. Review.

14.

Patient enrolment into HIV care and treatment within 90 days of HIV diagnosis in eight Rwandan health facilities: a review of facility-based registers.

Kayigamba FR, Bakker MI, Fikse H, Mugisha V, Asiimwe A, Schim van der Loeff MF.

PLoS One. 2012;7(5):e36792. doi: 10.1371/journal.pone.0036792. Epub 2012 May 11.

15.

Prospective long-term outcomes of a cohort of Ugandan children with laboratory monitoring during antiretroviral therapy.

Kekitiinwa A, Asiimwe AR, Kasirye P, Korutaro V, Kitaka S, Maganda A, Madalon M, Graziano FM.

Pediatr Infect Dis J. 2012 Aug;31(8):e117-25. doi: 10.1097/INF.0b013e31825cb9d6.

PMID:
22581223
16.

Determinants of circumcision and willingness to be circumcised by Rwandan men, 2010.

Gasasira RA, Sarker M, Tsague L, Nsanzimana S, Gwiza A, Mbabazi J, Karema C, Asiimwe A, Mugwaneza P.

BMC Public Health. 2012 Feb 18;12:134. doi: 10.1186/1471-2458-12-134.

17.

Is increasing complexity of algorithms the price for higher accuracy? virtual comparison of three algorithms for tertiary level management of chronic cough in people living with HIV in a low-income country.

Mukabatsinda C, Nguyen J, Bisig B, Lynen L, Coppens YD, Asiimwe A, Van den Ende J.

BMC Med Inform Decis Mak. 2012 Jan 19;12:2. doi: 10.1186/1472-6947-12-2.

18.

Safety and tolerability of antiretroviral therapy among HIV-infected children and adolescents in Uganda.

Tukei VJ, Asiimwe A, Maganda A, Atugonza R, Sebuliba I, Bakeera-Kitaka S, Musoke P, Kalyesubula I, Kekitiinwa A.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):274-80. doi: 10.1097/QAI.0b013e3182423668.

PMID:
22126740
19.

Safety and efficacy of the PrePex device for rapid scale-up of male circumcision for HIV prevention in resource-limited settings.

Bitega JP, Ngeruka ML, Hategekimana T, Asiimwe A, Binagwaho A.

J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):e127-34. doi: 10.1097/QAI.0b013e3182354e65.

PMID:
21909032
20.

Weekend admission and mortality from acute exacerbations of chronic obstructive pulmonary disease in winter.

Brims FJ, Asiimwe A, Andrews NP, Prytherch D, Higgins BR, Kilburn S, Chauhan AJ.

Clin Med. 2011 Aug;11(4):334-9.

PMID:
21853828
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk